PPT-Diagnostic Approach of Acromegaly

Mahtab Niroomand M D Assistant Professor of Endocrinology 2014 Tehran Out line Introduction and epidemiology Etiology and differential diagnosis Clinical features Survival Diagnostic modality. Collection, Packaging, Shipping. Overview. Sample Collection. Just In Time Training. Diagnostic Sampling: Overview. Before You Begin. Test specifications from laboratory. Samples needed, any special media . - . X-ray vision. http://www.bjwinslow.com/albums/medicalcharts/broken_arm_radius_and_ulna_x_ray_10.jpg. http://www.museumboerhaave.nl/AAcollection/AAJPEGS/M22/9955.jpg. http://www.uab.edu/surgonc/cases/GI/case2/ctscanof.htm. Dr Edward Hutchison FY1 (Geriatrics). Phase II Objectives. 3.21: . Investigations. . –. . Request appropriately the more common tests of thyroid, adrenal and pituitary gland function, seeking advice where necessary.. draft-raszuk-. bgp. -diagnostic-message-00. Robert Raszuk, . Enke Chen, Bruno Decraene. IETF 79, November 2010,. . Beijing, China. Agenda. Goals. Encoding. Diagnostic message TLVs. Goals. To enhance current practices for troubleshooting network connectivity problems .. especially on eBGP boundaries. People Management Network. 1. Overview of the session. Introduction to the project . An explanation of the Diagnostic. Conclusions – what I have learnt. Developed . from the Strengthening the Performance Framework Project. New diagnostic tests been studied extensively. Some 90% of immunogenicity. However, even fully therapeutic antibodies has been very successful. Well-known examples of are applied for inammatory disea Practical Endocrinology. Wendy Blount, DVM. The Pituitary Gland. Two parts. Adenohypophysis – anterior lobe. Pars distalis. Pars intermedia. Pars infundibularis. Neurohypophysis - posterior lobe. Growth Hormone (GH) = Somatotropin. William . Worodria. Mulago. . Hospital, . Kampala, Uganda . Outline. The burden of Respiratory Illness. The Diagnostic Approach to a patient with a “respiratory” presentation. Community Acquired Pneumonia. Acromegaly. Very rare. Prevalence in the order of 1 in 200,000. Usually diagnosed between age 40 and 60. No difference in gender susceptibility. Insidious onset. Pathogenesis. Most commonly caused by pituitary adenoma. SOURCE, COST AND COPYRIGHT ISSUESCopyright: Source:Department of Psychiatryashington University School of Medicine40 N. Kingshighway, Suite 4obins, L.N., Wing, J., Wittchen, H.-U., Helzer, J.E., Babor . therapeutic outcomes. . Fatemeh Rahmani. Agenda. . . 1.Introduction. 2.TherapeuticEnd-Points . ■ . BiochemicalGoals. ■ . Tumor Shrinkage . Acromegaly. Rahim. . Zahedi. MD. Introduction. Acromegaly. is a rare disease typically caused by an excess of growth hormone (GH) secretion from a pituitary adenoma. The active disease is characterized by elevations of both GH and insulin-like growth factor-1 (IGF1) and the failure of GH suppression in oral glucose tolerance test(OGTT). • Today . the pituitary gland is recognized for its . essential role . in body homeostasis, and for this reason it often is referred . to as . the “. master gland. .”. • The pituitary . is a very small gland, weighing between 0.4 and 1 g . Prolactinoma. . (on medical treatment) was referred to endocrine clinic for high IGF1 level and impaired GH-GTT test. Presented by Suzan . Maleki. MD. 2023 JAN. Patient ID. 41 y/o man. From . Amol.